Novelix Pharmaceuticals Limited (BOM:536565)

India · Delayed Price · Currency is INR

70.80

+3.37 (5.00%)

At close: Aug 4, 2026

Novelix Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	1,323	1,323	307.33	45.31	19.2	89.13
Revenue Growth	330.60%	330.60%	578.26%	135.96%	-78.45%	-7.01%
Gross Profit	56.24	56.24	11.47	6.86	5.38	6.18
Operating Income	34.04	34.04	1.27	0.38	-0.58	-4.82
Net Income	25.57	25.57	0.85	0.1	-0.6	-20.27
Earnings Per Share	1.21	1.21	0.09	0.01	-0.07	-2.50
EPS Growth	1244.44%	1244.44%	800.00%	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Pharma Business	1,323	1,323	295.09	1.45	2.13	78.55
Finance	-	-	0.16	2.04	2.73	2.98
Trading in Shares	-	-	12.09	41.15	11.91	7.56
Total	1,323	1,323	307.34	45.31	19.2	91.63

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	29.59	29.59	6.79	34.91	31.66	30.09
Total Debt	43.22	43.22	-	-	-	1.65
Net Cash (Debt)	-13.63	-13.63	6.79	34.91	31.66	28.44
Net Cash Growth	-	-	-80.56%	10.26%	11.31%	22.18%
Net Cash Per Share	-0.65	-0.65	0.72	3.35	3.91	3.51

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-223.89	-223.89	-136.85	-3.43	-24.05	15.86
Capital Expenditures	-32.56	-32.56	-1.06	-	-0.04	-17.98
Free Cash Flow	-256.45	-256.45	-137.91	-3.43	-24.1	-2.12
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	4.25%	4.25%	3.73%	15.14%	27.99%	6.94%
Operating Margin	2.57%	2.57%	0.41%	0.85%	-3.04%	-5.41%
Pretax Margin	2.57%	2.57%	0.40%	0.47%	-3.05%	-22.83%
Profit Margin	1.93%	1.93%	0.27%	0.23%	-3.12%	-22.74%
FCF Margin	-19.38%	-19.38%	-44.87%	-7.58%	-125.49%	-2.38%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 5, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	58.51	43.49	313.26	1337.29	-	-
PS Ratio	1.13	0.84	0.86	3.07	3.80	0.81